Skip to main content
Top
Published in: Pathology & Oncology Research 3/2020

01-07-2020 | Original Article

Pancreatic Intraepithelial Neoplasia (PanIN) as a Morphologic Marker of Pancreatobiliary Type of Ampullary Carcinoma

Authors: Kritika Krishnamurthy, Vathany Sriganeshan

Published in: Pathology & Oncology Research | Issue 3/2020

Login to get access

Abstract

The classification of ampullary adenocarcinoma into intestinal and pancreatobiliary sub-types has been found to be important in predicting prognosis and determining therapeutic strategy. Due to considerable inter-observer variability in sub-typing based solely on morphology, higher frequency of poorly differentiated cancers and low incidence of the disease, the histomorphologic classification of ampullary adenocarcinoma remains one of the grey zones in surgical pathology. Pan-IN is a well recognized precursor to pancreatic adenocarcinoma. Three studies have shown concurrent Pan-IN in patients with ampullary carcinoma, but their association with the two sub-types has not yet been reported. Fourteen cases of surgical resection for ampullary adenocarcinoma were retrieved from the archives. The cases were classified into two groups based on the presence or absence of concomitant Pan-IN. All the cases were stained for CK7, CK 20, Villin and CDX 2 and were classified as intestinal or pancreatobiliary types based on the staining pattern. All the 10 cases with Pan-IN stained negative for CDX2 and were classified as pancreatobiliary type (p = 0.01). Of the cases without Pan-IN, 3 were classified as intestinal sub-type based on morphology and CDX2 positivity and 1 was classified as pancreatobiliary type. Concomitant Pan-IN was present in 91% of pancreatobiliary type of ampullary adenocarcinoma. The grade of Pan-IN did not influence the grade or stage of the adenocarcinoma (p > 0.05). The co-occurrence of Pan-IN in a high percentage of the pancreatobiliary sub-type and its complete absence in the intestinal sub-type may serve as a strong differentiator between the two sub-types.
Literature
1.
go back to reference Albores-Saavedra J, Schwartz AM, Batich K, Henson DE (2009) Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 100:598–605CrossRef Albores-Saavedra J, Schwartz AM, Batich K, Henson DE (2009) Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 100:598–605CrossRef
2.
go back to reference Benhamiche AM, Jouve JL, Manfredi S, Prost P, Isambert N et al (2000) Cancer of the ampulla of Vater: results of a 20-year population-based study. Eur J Gastroenterol Hepatol 12:75–79CrossRef Benhamiche AM, Jouve JL, Manfredi S, Prost P, Isambert N et al (2000) Cancer of the ampulla of Vater: results of a 20-year population-based study. Eur J Gastroenterol Hepatol 12:75–79CrossRef
3.
go back to reference Winter JM, Cameron JL, Olino K, Herman JM, Jong MC et al (2010) Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 14:379–387CrossRef Winter JM, Cameron JL, Olino K, Herman JM, Jong MC et al (2010) Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 14:379–387CrossRef
4.
go back to reference Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y (1994) Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res 85(2):161–166CrossRef Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y (1994) Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res 85(2):161–166CrossRef
5.
go back to reference Bronsert P, Kohler I, Werner M, Makowiec F, Kuesters S, Hoeppner J, Hopt UT, Keck T, Bausch D, Wellner UF (2013) Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin. BMC Cancer 13:428CrossRef Bronsert P, Kohler I, Werner M, Makowiec F, Kuesters S, Hoeppner J, Hopt UT, Keck T, Bausch D, Wellner UF (2013) Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin. BMC Cancer 13:428CrossRef
6.
go back to reference Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F et al (2009) Histopathologic features and microsatellite instability of cancers of the papilla of Vater and their precursor lesions. Am J Surg Pathol 33:691–704CrossRef Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F et al (2009) Histopathologic features and microsatellite instability of cancers of the papilla of Vater and their precursor lesions. Am J Surg Pathol 33:691–704CrossRef
7.
go back to reference Albores-Saavedra J, Henson DE, Klimstra DS (2000) Malignant tumors of the ampulla. In:Tumors of the gallbladder extrahepatic bile ducts and ampulla of vater Armed Forces Institute of Pathology. Washington D.C, 259–316 Albores-Saavedra J, Henson DE, Klimstra DS (2000) Malignant tumors of the ampulla. In:Tumors of the gallbladder extrahepatic bile ducts and ampulla of vater Armed Forces Institute of Pathology. Washington D.C, 259–316
8.
go back to reference Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OPF, Gladhaug IP (2008) Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMCCancer 8:170 Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OPF, Gladhaug IP (2008) Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMCCancer 8:170
9.
go back to reference Rosa VDL, Peria FM, Brunaldi MO (2017) Carcinoma of ampulla of Vater: carcinogenesis and Immunophenotypic evaluation. J Clin Epigenet 3(2):25 Rosa VDL, Peria FM, Brunaldi MO (2017) Carcinoma of ampulla of Vater: carcinogenesis and Immunophenotypic evaluation. J Clin Epigenet 3(2):25
10.
go back to reference Ang DC, Shia J, Tang LH (2014) The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of Vater. Am J Surg Pathol 38:1371–1379CrossRef Ang DC, Shia J, Tang LH (2014) The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of Vater. Am J Surg Pathol 38:1371–1379CrossRef
11.
go back to reference Chang DK, Jamieson NB, Johns AL (2013) Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater. J Clin Oncol 31:1348–1356CrossRef Chang DK, Jamieson NB, Johns AL (2013) Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater. J Clin Oncol 31:1348–1356CrossRef
12.
go back to reference Liu TH, Chen J, Zeng XJ (1983) Histogenesis of pancreatic head and ampullary region carcinoma. Chin Med J 96:167–174PubMed Liu TH, Chen J, Zeng XJ (1983) Histogenesis of pancreatic head and ampullary region carcinoma. Chin Med J 96:167–174PubMed
13.
go back to reference Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE et al (2001) Neoplasms of the ampulla of Vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Mod Pathol 14:139–143CrossRef Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE et al (2001) Neoplasms of the ampulla of Vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Mod Pathol 14:139–143CrossRef
14.
go back to reference Cattel RB, Pyrtek LJ (1949) An appraisal of pancreatoduodenal resection: a follow-up study of 61 cases. Ann Surg 129:840–848CrossRef Cattel RB, Pyrtek LJ (1949) An appraisal of pancreatoduodenal resection: a follow-up study of 61 cases. Ann Surg 129:840–848CrossRef
15.
go back to reference Kimura W, Futakawa N, Zhao B (2004) Neoplastic diseases of the papilla of Vater. J Hepato-Biliary-Pancreat Surg 11:223–231CrossRef Kimura W, Futakawa N, Zhao B (2004) Neoplastic diseases of the papilla of Vater. J Hepato-Biliary-Pancreat Surg 11:223–231CrossRef
16.
go back to reference Zhou H, Schaefer N, Wolff M, Fischer H (2004) Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol 28:875–882CrossRef Zhou H, Schaefer N, Wolff M, Fischer H (2004) Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol 28:875–882CrossRef
17.
go back to reference Fischer HP, Zhou H (2000) Pathologie der Papilla Vateri. In: Doerr W, Seifert G, Uehlinger E (eds) Spezielle Pathologische Anatomie: Pathologie der Leber und der Gallenwege, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 1219–1257CrossRef Fischer HP, Zhou H (2000) Pathologie der Papilla Vateri. In: Doerr W, Seifert G, Uehlinger E (eds) Spezielle Pathologische Anatomie: Pathologie der Leber und der Gallenwege, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 1219–1257CrossRef
18.
go back to reference Sessa F, Furlan D, Zampatti C, Carnevali I, Franzi F, Capella C (2007) Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch 451:649–657CrossRef Sessa F, Furlan D, Zampatti C, Carnevali I, Franzi F, Capella C (2007) Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch 451:649–657CrossRef
19.
go back to reference Schueneman A, Wang H, Soifer HS, Schnabel CA, Wolff RA, Varadhachary GR, Overman MJ (2014) Molecular classification of ampullary adenocarcinoma: comparative prognostic performance of the 92-gene assay versus histomolecular analysis. J Clin Oncol 32(15):4141–4141CrossRef Schueneman A, Wang H, Soifer HS, Schnabel CA, Wolff RA, Varadhachary GR, Overman MJ (2014) Molecular classification of ampullary adenocarcinoma: comparative prognostic performance of the 92-gene assay versus histomolecular analysis. J Clin Oncol 32(15):4141–4141CrossRef
20.
go back to reference Perkins G, Svrcek M, Bouchet-Doumenq C, Voron T, Colussi O, Debove C, et al. (2019) Can we classify ampullary tumours better? Clinical, pathological and molecularfeatures. Results of an AGEO study. Br J Cancer [Epub ahead of print] Perkins G, Svrcek M, Bouchet-Doumenq C, Voron T, Colussi O, Debove C, et al. (2019) Can we classify ampullary tumours better? Clinical, pathological and molecularfeatures. Results of an AGEO study. Br J Cancer [Epub ahead of print]
21.
go back to reference Jeong BK, Sung YN, Kim SJ, An S, Park H, Hwang HS, Kang HJ, Lee JH, Song KB, Kim KP, Hwang DW, Lee SS, Kim SC, Hong SM (2019) High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas. Hum Pathol 84:92–104CrossRef Jeong BK, Sung YN, Kim SJ, An S, Park H, Hwang HS, Kang HJ, Lee JH, Song KB, Kim KP, Hwang DW, Lee SS, Kim SC, Hong SM (2019) High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas. Hum Pathol 84:92–104CrossRef
Metadata
Title
Pancreatic Intraepithelial Neoplasia (PanIN) as a Morphologic Marker of Pancreatobiliary Type of Ampullary Carcinoma
Authors
Kritika Krishnamurthy
Vathany Sriganeshan
Publication date
01-07-2020
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2020
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-019-00754-6

Other articles of this Issue 3/2020

Pathology & Oncology Research 3/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine